Status:
COMPLETED
Directly Observed Therapy in HIV Infected Adolescent Focus Groups
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
HIV Infections
Eligibility:
All Genders
16-21 years
Brief Summary
The purpose of this study is to help researchers use information from HIV infected adolescents to design a directly observed therapy (DOT) program that will help adolescents take their anti-HIV medica...
Detailed Description
The rate of HIV infection among adolescents is increasing at an alarming rate. Adherence to antiretroviral therapy has been a major challenge in achieving and maintaining adequate control of the disea...
Eligibility Criteria
Inclusion
- HIV infected due to high-risk behavior
- Regular attendee of local adolescent HIV support group
- Current use of antiretrovirals or history of antiretroviral therapy
- Permission of parent or legal guardian if participant is less than the legal age of consent. Assent of the minor participant should be obtained where required.
Exclusion
- Perinatal HIV infection
- Visibly distraught or emotionally unstable
- Pregnancy or breast-feeding
Key Trial Info
Start Date :
April 1 2004
Trial Type :
OBSERVATIONAL
End Date :
July 1 2004
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00079729
Start Date
April 1 2004
End Date
July 1 2004
Last Update
October 29 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles County Medical Center/USC
Los Angeles, California, United States, 90033
2
University of Miami (Pediatric)
Miami, Florida, United States, 33136
3
St. Jude Childrens Research Hospital, Memphis
Memphis, Tennessee, United States, 38105-2794